The aim of this study was to assess the effect of rTMS treatment on the symptoms of MDD and also to test whether there is an association between serum VEGF levels and improvement of the symptoms (included anhedonia assessed with a specific instrument) in patients with MDD after rTMS treatment. Here, VEGFA is linked to major depressive disorder.